|
Role of Manahshiladi Anjana and Jeevantyadi Ghrita on Linganasha - Cataract
Manjusha Rajagopala1, Kulwant Singh2, HJ Mankodi3, Narayan Bavalatti4
1 Reader, Dept. of Shalakya, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, India
2 Formerly Professor & Head, Dept. of Shalakya, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, India
3 Formerly Professor, Dept. of Shalakya, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, India
4 Ph.D. Scholar, Dept. of Shalakya, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, India
Correspondence Address:
Manjusha Rajagopala
Reader, Dept. of Shalakya, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar
India
 Source of Support: None, Conflict of Interest: None  | Check |
|
|
Cataract - Linganasha is defined as loss of transparency of lens developing as a result of altered physiological process within its substance. The disease Linganasha is mainly due to vitiation of Kapha Dosha. According to the 1992 the status report of DGHS, Govt. of India, Cataract alone is responsible for 81% cases of blindness. While the problem of blindness is global, its magnitude is much higher in India. Of the estimated 45 million, India alone has 12 million blind people. In this study patients were selected from the O.P.D. and I.P.D. of Shalya - Shalakya dept and randomly divided into three groups i.e. in Group-A Manahshiladi Anjana (Local application), Group-B Jeevantyadi Ghrita (Internal use) and in Group - C Rasanjana Netra Bindu and Godanti Cap. 500 mg. (Control group) were administered for 6 months. In this study total 195 patients were registered and 99 patients completed the course of treatment. Maximum relief was observed on Polyopia / Diplopia in Group A and B, whereas increase in the clinical features was found in Group C. |
